Rapamycin and its derivative possess anti-atherosclerosis activity,but its effects on adhesion molecule expression and macrophage adhesion to endothelial cells
Apatinib,a small-molecule Inhibitor of VEGFR-2,has attracted much attention due to its encouraging anticancer activity in third-line clinical treatment for many